Close
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion May 29, 2024 07:02AM

Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion

This acquisition reflects the significant clinical progress achieved with Restoret™, EyeBio’s novel late-phase candidate for diabetic macular edema, as well as a preclinical pipeline targeting retinal diseases -

Restoret anticipated to enter pivotal study for diabetic macular edema in the second half of 2024


Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion May 29, 2024 07:02AM

Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion

This acquisition reflects the significant clinical progress achieved with Restoret™, EyeBio’s novel late-phase candidate for diabetic macular edema, as well as a preclinical pipeline targeting retinal diseases -

Restoret anticipated to enter pivotal study for diabetic macular edema in the second half of 2024


Gildan Activewear Reports on Shareholders’ Voting Results May 29, 2024 07:00AM

MONTRÉAL, May 29, 2024 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) today announced that the eight director nominees, being all of the existing directors of the Company following the resignation on May 23, 2024 of the prior members of the board of directors, were elected as directors of the Company for the ensuing year by an overwhelming majority of the votes cast by shareholders, in-person, and by proxy, at its... (continue reading...)


Sable Stakes Additional Ground Along the Perk Rocky Regional Trend in BC, Canada May 29, 2024 07:00AM

VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- Sable Resources Ltd. ("Sable" or the "Company") (TSXV:SAE | OTCQB: SBLRF) is pleased to announce that it has staked 4,806 hectares of prospective ground in two properties located NW and SE of the Perk Rocky Project in British Columbia.

Dr. Ruben Padilla, President and CEO of Sable stated, “Following the Company’s entering into the option agreement for the Perk Rocky Project, Sable is pursuing... (continue reading...)


Valore Update of Hatchet Lake Uranium Project May 29, 2024 07:00AM

VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- ValOre Metals Corp. (“ValOre”, or the “Company”) (TSX-V: VO, OTCQB: KVLQF, Frankfurt: KEQ0) today provided an update regarding its Hatchet Lake Uranium Property.

Jim Paterson, Chairman and CEO, ValOre Metals Corp. stated: “We have partnered with knowledgeable investors with significant experience in Canada’s uranium exploration sector to help unlock value from our highly prospective Hatchet... (continue reading...)


More Globe Newswire

View Older Stories

May 29, 2024 07:00AM Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
May 29, 2024 07:00AM Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
May 29, 2024 07:00AM Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
May 29, 2024 07:00AM Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
May 29, 2024 07:00AM ProKidney to Participate in the Jefferies Global Healthcare Conference
May 29, 2024 07:00AM The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
May 29, 2024 07:00AM Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
May 29, 2024 07:00AM Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 29, 2024 07:00AM Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
May 29, 2024 07:00AM Kymera Therapeutics to Participate in Upcoming June Investor Conferences
May 29, 2024 07:00AM Plum Teams Up with hireEZ to Improve Recruiting Outcomes Through Job Matching
May 29, 2024 07:00AM Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
May 29, 2024 07:00AM Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
May 29, 2024 07:00AM Plymouth Industrial REIT to Present at Nareit’s REITweek 2024
May 29, 2024 07:00AM Lotus Technology Reports Unaudited First Quarter 2024 Financial Results
May 29, 2024 07:00AM Bitfarms Responds to Unsolicited Proposal from Riot Platforms
May 29, 2024 07:00AM Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Brain Diseases
May 29, 2024 07:00AM Cielo Announces Appointment of New Auditor
May 29, 2024 07:00AM Athira Pharma to Participate in Upcoming June Conferences
May 29, 2024 07:00AM Dragonfly Energy to Participate in June 2024 Conferences
May 29, 2024 07:00AM Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
May 29, 2024 07:00AM Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
May 29, 2024 07:00AM Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
May 29, 2024 07:00AM TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
May 29, 2024 07:00AM Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
May 29, 2024 07:00AM ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024
May 29, 2024 07:00AM Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)
May 29, 2024 07:00AM OTC Markets Group Welcomes Verde Agritech Ltd. to OTCQX
May 29, 2024 07:00AM Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
May 29, 2024 07:00AM OTC Markets Group Welcomes Marpai, Inc. to OTCQX
May 29, 2024 07:00AM Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024
May 29, 2024 07:00AM MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
May 29, 2024 07:00AM IGM Biosciences to Present at the Jefferies Healthcare Conference
May 29, 2024 07:00AM Kymera Therapeutics to Participate in Upcoming June Investor Conferences
May 29, 2024 07:00AM The Habit Burger Grill Opens New Drive-Thru in Fresno, Its Fifth Location in the California City
May 29, 2024 07:00AM Immunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma
May 29, 2024 06:58AM "Charm of Jiangsu" International Photography Project: Experiencing the Flavor of Happiness
May 29, 2024 06:58AM "Charm of Jiangsu" International Photography Project: Experiencing the Flavor of Happiness
May 29, 2024 06:46AM Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
May 29, 2024 06:45AM Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
May 29, 2024 06:45AM Castellum, Inc. Announces Leadership Changes
May 29, 2024 06:44AM Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
May 29, 2024 06:40AM Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides
May 29, 2024 06:37AM Man Group PLC : Form 8.3 - Barratt Developments plc
May 29, 2024 06:33AM Audit Committee Chair Confirmation
May 29, 2024 06:30AM Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR Wild-Type Non-Small Cell Lung Cancer
May 29, 2024 06:30AM Cybersecurity Skills Shortage Is Ranked as the Biggest Risk to MSPs and Their Clients
May 29, 2024 06:30AM Global 50 Manufacturing Giant Trusts eGain for Knowledge-Powered Customer Service
May 29, 2024 06:30AM Radisson Expands Drill Program to 35,000 Metres at the O’Brien Gold Project in Quebec
May 29, 2024 06:30AM Casey House creates fictitious drug, Stigmavir, to smash HIV stigma within the health care system
View Older Stories